av/panbela-therapeutics--big.svg

COM:PANBELA

Panbela Therapeutics

  • Stock

USD

Last Close

0.35

22/11 20:00

Market Cap

1.71M

Beta: -

Volume Today

5.21K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-107.04K
-
-4.93M
4,502.78%
-5.11M
3.75%
-10.37M
102.93%
-5.91M
43.08%
-6.20M
5.00%
-4.77M
23.10%
-10.13M
112.56%
-34.93M
244.68%
-25.26M
27.68%
depreciation and amortization
9.58K
-
28K
192.34%
28K
0%
2.07M
-
114K
94.48%
deferred income tax
-1.00M
-
-2.07M
-
-114K
94.48%
stock based compensation
976K
-
902K
7.58%
1.73M
92.13%
1.28M
26.20%
1.09M
14.54%
1.21M
10.25%
1.29M
6.80%
1.09M
15.46%
823K
24.36%
change in working capital
52.04K
-
26K
50.03%
1.77M
6,715.38%
-62K
103.50%
494K
896.77%
188K
61.94%
-188K
200%
2.14M
1,240.43%
559K
73.93%
7.06M
1,162.97%
accounts receivables
-3.28K
-
-31K
-
-2K
93.55%
51K
2,650%
212K
315.69%
inventory
76.12K
-
31K
-
2K
93.55%
-51K
2,650%
-212K
315.69%
accounts payables
-3.65K
-
681K
18,737.11%
1.15M
69.16%
-319K
127.69%
360K
212.85%
301K
16.39%
-747K
348.17%
631K
184.47%
2.25M
256.42%
7.06M
213.92%
other working capital
-17.15K
-
-655K
3,719.46%
620K
194.66%
257K
58.55%
134K
47.86%
-113K
184.33%
559K
594.69%
1.51M
170.66%
-1.69M
211.70%
-7.06M
317.75%
other non cash items
33.98K
-
1.00M
2,854.94%
12K
98.80%
5.30M
44,075%
1.75M
67.08%
2.18M
24.93%
-103K
104.72%
18.01M
-
-7.87M
143.69%
net cash provided by operating activities
-11.45K
-
-3.90M
33,926.02%
-2.40M
38.47%
-3.40M
41.87%
-2.39M
29.84%
-2.74M
14.75%
-3.85M
40.71%
-6.70M
73.95%
-15.28M
127.86%
-25.25M
65.29%
investments in property plant and equipment
-660K
-
acquisitions net
4K
-
purchases of investments
sales maturities of investments
500K
-
other investing activites
124.72K
-
-540K
-
400K
-
net cash used for investing activites
124.72K
-
500K
300.90%
-540K
-
-656K
21.48%
400K
160.98%
debt repayment
-8.32K
-
-14K
-
-186K
1,228.57%
-860K
362.37%
common stock issued
1.51M
-
1.87M
23.79%
2.33M
-
3.16M
35.74%
11.08M
250.66%
9.05M
18.29%
5.35M
40.92%
1.60M
70.14%
common stock repurchased
dividends paid
other financing activites
1.16M
-
42K
96.39%
3.11M
7,295.24%
1.33M
57.21%
810K
39.05%
223K
72.47%
1.04M
366.82%
5K
99.52%
24.55M
490,800%
net cash used provided by financing activities
-8.32K
-
2.67M
32,263.04%
1.92M
28.41%
3.11M
62.19%
3.64M
17.29%
3.78M
3.87%
10.44M
176.00%
10.10M
3.34%
5.35M
46.96%
26.14M
388.27%
effect of forex changes on cash
-7K
-
-4K
42.86%
10K
350%
-3K
130%
-1K
66.67%
-17K
1,600%
-6K
64.71%
-4K
33.33%
net change in cash
104.95K
-
-729K
794.62%
-487K
33.20%
-286K
41.27%
1.25M
538.11%
1.04M
16.68%
6.57M
529.60%
2.85M
56.72%
-10.58M
471.95%
1.29M
112.22%
cash at beginning of period
58.82K
-
1.65M
2,711.87%
925K
44.07%
438K
52.65%
152K
65.30%
1.41M
824.34%
2.45M
74.31%
9.02M
268.40%
11.87M
31.53%
1.28M
89.17%
cash at end of period
163.77K
-
925K
464.81%
438K
52.65%
152K
65.30%
1.41M
824.34%
2.45M
74.31%
9.02M
268.40%
11.87M
31.53%
1.28M
89.17%
2.58M
100.62%
operating cash flow
-11.45K
-
-3.90M
33,926.02%
-2.40M
38.47%
-3.40M
41.87%
-2.39M
29.84%
-2.74M
14.75%
-3.85M
40.71%
-6.70M
73.95%
-15.28M
127.86%
-25.25M
65.29%
capital expenditure
-660K
-
free cash flow
-11.45K
-
-3.90M
33,926.02%
-2.40M
38.47%
-3.40M
41.87%
-2.39M
29.84%
-2.74M
14.75%
-3.85M
40.71%
-6.70M
73.95%
-15.94M
137.71%
-25.25M
58.44%

All numbers in USD (except ratios and percentages)